Stocktoria
Entrada Therapeutics, Inc. TRDA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-10-29
Entrada Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,693,867 | $24.1M |
| MILLENNIUM MANAGEMENT LLC | 519,356 | $6.6M |
| CITADEL ADVISORS LLC | 215,018 | $2.7M |
| RENAISSANCE TECHNOLOGIES LLC | 202,084 | $2.6M |
| AQR CAPITAL MANAGEMENT LLC | 79,493 | $1.0M |
| D. E. Shaw & Co., Inc. | 79,047 | $997,573 |
| TWO SIGMA INVESTMENTS, LP | 44,602 | $562,877 |
Source: SEC EDGAR filings · CIK 0001689375 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.